Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30.08 USD | +0.84% |
|
+13.04% | +28.93% |
Jul. 16 | Barclays Raises Price Target on RXO to $30 From $24, Maintains Overweight Rating | MT |
Jul. 09 | JPMorgan Adjusts Price Target on RXO to $25 From $16, Maintains Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.93% | 3.51B | |
-0.18% | 44.29B | |
-16.07% | 18.16B | |
+15.70% | 13.51B | |
+17.47% | 13.39B | |
-3.22% | 6.78B | |
-11.00% | 2.41B | |
+16.64% | 1.79B | |
-11.92% | 1.49B | |
+20.16% | 1.46B |
- Stock Market
- Equities
- RXO Stock
- News RXO, Inc.
- Goldman Sachs Adjusts Price Target on RXO to $22 From $20, Maintains Neutral Rating